One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients

CONCLUSIONS: The authors have demonstrated that the one-year persistence of RAAS inhibitor FDCs varies significantly in hypertensive patients. ACE inhibitor/CCB FDCs were found to be the most advantageous. Orv Hetil. 2023; 164(34): 1337-1341.PMID:37634155 | DOI:10.1556/650.2023.32840

Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: G ábor Simonyi Tam ás Ferenci Ervin Finta Mih ály Medvegy Istv án Wittmann Source Type: research